TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: hydration measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: erythema measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percent change in fasting TG versus placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent change in fasting TG versus fenofibrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Finger pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time-to-Treatment Discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Online dating addiction scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pinch grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremity strength and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive airway pressure adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Chinese Legibility Scale (CLS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline Chinese Handwriting Evaluation Form (CHEF)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Maternal Hemoglobin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Peer support skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent change in nocturnal systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transplant engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in knowledge about child maltreatment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in behavior regarding child maltreatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Migraine Disability Assessment Questionnaire (MIDAs)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Preoperative frailty markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in self-efficacy expectations for pelvic floor exercises
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in outcome expectations for pelvic-floor exercise treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: subjective effect on mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Angers CT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein turnover in tendon tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Margin events
Endpoint domain: Adverse events/effects
Primary endpoint: Short form-36 (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Western Ontario and Mcmaster Universities Osteoarthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent AF/AFL episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total Body Weight Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of liver reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients identified as having diagnosed but untreated HCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients identified as having diagnosed but untreated HCV that are re-linked to HCV care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Plasma concentration of sphingomyelin to total HDL mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax of PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Tmax of PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUC of PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Gut microbiota metabolic pathways changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Subjective Visual Vertical constant error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Haptic Vertical constant error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Postural Vertical constant error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary measurement at time of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Increase in prescribed HFrEF therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of time in glucose target range (glucose level 100mg/dl-125mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Score of common cold and sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly Number of Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Headache Measured by Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine Disability Assessment Test Total Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of acute esophageal thermal injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pressure Pain Threshold Measurement with Algometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of gingival index (Löe Silness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute kidney injury subphenotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Standard deviation of regional ventilation delay index (RVDsd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Crestal bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Buccal bone thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Diagnosis of community acquired pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MG-related functional impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Amount of opiates (morphine equivalent) consumed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amount of anti-emetics consumed (Ondansetron)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of serum B12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severe acute COVID-19 infection
Endpoint domain: Mortality/survival
Primary endpoint: Agreement between the test devices and predicate device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of the test devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the test devices
Endpoint domain: Adverse events/effects
Primary endpoint: Complete Adherence to LAI-PrEP/ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants receiving ACT therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Consumption of local anesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Face, Legs, Activity, Cry and Consolability (FLACC) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AKI nonresolving subphenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Visual Memory Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Non-Verbal Reasoning Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in regional microglial activation and tau pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in regional synaptic density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metastatic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Win Ratio of Composite Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Cardiovascular Deaths
Endpoint domain: Mortality/survival
Primary endpoint: Change in High Contrast Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline Tardieu XV3 angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean change from baseline passive range of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Nurse's decision support skills
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Diagnostic sensitivity of AngioQFA for coronary ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic sensitivity of AngioIMR for coronary microvascular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic specificity of AngioQFA for coronary ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic specificity of AngioIMR for coronary microvascular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in D-KEFS Trails T-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in D-KEFS Verbal Fluency T-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in WAIS Digit Span T-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improved quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feasibility of using the collaborative care model integration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of using the collaborative care model integration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thirst score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the curve concentration-time (AUC(0-504)) of pembrolizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Reactions (ARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge and skills of nurses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total Number of Tests Among Network Members Referred for COVID Testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Number of Vaccinations Among Study Participants Given COVID Vaccine Information
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pathologic response (biopsy positivity rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in leg lean muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: device related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: bacterial load reduction - Staphylococcus aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: wound surface area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: End inspiratory transpulmonary pressure (PL-insp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Relationship between Anti KU antibodies and Systemic Lupus Erythematosus manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pocket Probing depths change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding on Probing change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracheal intubation associated event (TIAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Oral Wound Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to detect sentinel lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Trough concentration of LPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent treatment-related Grade 3 and non-life threatening Grade 4 toxicity or single occurrence of life-threatening Grade 4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: The Good Touch subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Bad Touch subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional recovery after ORIF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers diagnostic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VTE events (DVT and PE)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of transfusion support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with IL-11 detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle stiffness/spasticity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggregability analyzed by optical aggregometry-ADP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in naming ability at week 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in naming ability at week 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluorescence intensity of at least 30% (ΔR30)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluorescence intensity of at least 120% (ΔR120)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in VISA-A
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants With Sufficiency of Serum Bactericidal Assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of Ventilator Associated Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Class attendance feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Enrollment retention feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall helpfulness of the course
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrence of PTC
Endpoint domain: Mortality/survival
Primary endpoint: Change in 24-hour Mean Arterial Pressure (MAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knee injury and Osteoarthritis Outcome Score (KOOS) Pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Unnecessary biopsy rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Timeliness of birth dose vaccine administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Correction of spontaneous hyperventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cardiac output values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-year Disease-Free Survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Quality of life related to swallowing function
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tolerance to oral intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recorded signal quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of the 360-degree turn test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of etiologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: intubation efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall difficulty score - T1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-operative recovery of kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: total muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early Rate of Gastrointestinal Toxicity grade 2 or more
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of globe akinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician's global aesthetic improvement assessment (CGAIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Memory test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of smokers among patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial gait parameters and symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporal gait parameters and symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limb motor functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Kt/V urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Achieving Kt/V urea ≥ 1.7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean daily ultrafiltration (UF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Size of mastoid cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of new brain lesions on DWI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Oral-health Related Quality of life (OHRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the Receiver Operating Characteristic curve (AUROC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total live birth rate
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to Prescription
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Withdrawal of consent rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of contamination
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of i-PRF in root resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Outcomes in Routine Evaluation 10 (CORE-10)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Process of Recovery Questionnaire (QPR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety and tolerability of EXL01
Endpoint domain: Adverse events/effects
Primary endpoint: Longitudinal growth trajectories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Markers of infant metabolic health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression free survival at 6 months (PFS-6)
Endpoint domain: Mortality/survival
Primary endpoint: Median time of radiographic healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale for Pain (VAS-P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological resolution of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes